[{"orgOrder":0,"company":"Zuellig Pharma","sponsor":"Moderna Therapeutics","pharmaFlowCategory":"D","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Vaccine","year":"2021","type":"Agreement","leadProduct":"mRNA-1273","moa":"SARS-CoV-2 spike protein","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Zuellig Pharma","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Zuellig Pharma \/ Zuellig Pharma","highestDevelopmentStatusID":"12","companyTruncated":"Zuellig Pharma \/ Zuellig Pharma"},{"orgOrder":0,"company":"Zuellig Pharma","sponsor":"Luye Pharma","pharmaFlowCategory":"D","therapeuticArea":"Psychiatry\/Psychology","country":"CHINA","productType":"Small molecule","year":"2021","type":"Agreement","leadProduct":"Quetiapine Hemifumarate","moa":"","graph1":"Psychiatry\/Psychology","graph2":"Approved","graph3":"Zuellig Pharma","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Immediate-Release Tablet","sponsorNew":"Zuellig Pharma \/ Zuellig Pharma","highestDevelopmentStatusID":"12","companyTruncated":"Zuellig Pharma \/ Zuellig Pharma"},{"orgOrder":0,"company":"Zuellig Pharma","sponsor":"Eli Lilly","pharmaFlowCategory":"D","therapeuticArea":"Psychiatry\/Psychology","country":"U.S.A","productType":"Small molecule","year":"2024","type":"Acquisition","leadProduct":"Tadalafil","moa":"","graph1":"Psychiatry\/Psychology","graph2":"Approved","graph3":"Zuellig Pharma","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Zuellig Pharma \/ Zuellig Pharma","highestDevelopmentStatusID":"12","companyTruncated":"Zuellig Pharma \/ Zuellig Pharma"}]

Find Clinical Drug Pipeline Developments & Deals by Zuellig Pharma

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Pharma, Lab & Chemical Expo
                          Not Confirmed
                          Pharma, Lab & Chemical Expo
                          Not Confirmed

                          Details : Through the acquisition, Zuellig will access Cialis (tadalafil) for erectile dysfunction and Alimta (pemetrexed) for pleural mesothelioma and non-small cell lung cancer from Eli Lilly.

                          Brand Name : Cialis

                          Molecule Type : Small molecule

                          Upfront Cash : Undisclosed

                          February 06, 2024

                          Lead Product(s) : Tadalafil

                          Therapeutic Area : Psychiatry/Psychology

                          Highest Development Status : Approved

                          Recipient : Eli Lilly

                          Deal Size : Undisclosed

                          Deal Type : Acquisition

                          blank

                          02

                          Pharma, Lab & Chemical Expo
                          Not Confirmed
                          Pharma, Lab & Chemical Expo
                          Not Confirmed

                          Details : Luye grants Zuellig exclusive rights to distribute Seroquel (quetiapine fumarate, immediate release) and Seroquel XR (extended release formulation), atypical anti-psychotic medicines with antidepressant properties, for schizophrenia & bipolar disorder, i...

                          Brand Name : Seroquel

                          Molecule Type : Small molecule

                          Upfront Cash : Undisclosed

                          August 02, 2021

                          Lead Product(s) : Quetiapine Hemifumarate

                          Therapeutic Area : Psychiatry/Psychology

                          Highest Development Status : Approved

                          Recipient : Luye Pharma

                          Deal Size : Undisclosed

                          Deal Type : Agreement

                          blank

                          03

                          Pharma, Lab & Chemical Expo
                          Not Confirmed
                          Pharma, Lab & Chemical Expo
                          Not Confirmed

                          Details : Zuellig Pharma’s division, ZP Therapeutics will supply, mRNA-1273, the COVID-19 Vaccine Moderna in Southeast Asia, Hong Kong, Macau and Taiwan.

                          Brand Name : mRNA-1273

                          Molecule Type : Vaccine

                          Upfront Cash : Undisclosed

                          April 29, 2021

                          Lead Product(s) : mRNA-1273

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Approved

                          Recipient : Moderna Therapeutics

                          Deal Size : Undisclosed

                          Deal Type : Agreement

                          blank